MetaCap

Achieve Life Sciences Quarterly Balance Sheet

NASDAQ: QUITHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

5.56-0.31 (-5.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Achieve Life Sciences financial position

As of Sep 30, 2026, Achieve Life Sciences reported total assets of $206.4 million, up 296.7% from a year earlier against total liabilities of $25.7 million. Shareholders' equity stood at $180.7 million, or 87.6% of assets. The company held $59.7 million in cash and equivalents.

The current ratio (current assets divided by current liabilities) was 10.49, meaning short-term assets cover obligations due within a year.

Summary generated from market data by MetaCap's automated system. Methodology

Achieve Life Sciences balance sheet (quarterly)

Achieve Life Sciences quarterly balance sheet
Quarter (USD)Q3 20262026-09-30Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31Q4 20232023-12-31
Cash & Equivalents59.74M47.96M28.08M20.93M31.93M51.87M13.02M12.75M9.54M14.76M66.40M15.55M
Short-Term Investments141.78M139.34M1.19M15.47M16.18M3.52M10.23M21.61M33.37M46.56M——
Total Current Assets203.41M188.29M31.06M39.89M50.05M56.90M25.00M36.47M45.53M62.52M67.71M16.98M
Property, Plant & Equipment———3.00K———8.00K———13.00K
Goodwill1.03M1.03M1.03M1.03M1.03M1.03M1.03M1.03M1.03M1.03M1.03M1.03M
Intangible Assets584.00K640.00K696.00K751.00K807.00K863.00K918.00K974.00K1.03M1.09M1.14M1.20M
Total Assets206.42M190.44M33.10M41.79M52.04M58.94M27.36M38.63M47.92M64.79M70.03M19.37M
Accounts Payable————1.94M1.22M1.66M1.95M1.01M550.00K373.00K618.00K
Total Current Liabilities19.39M197.66M11.83M9.08M9.73M8.57M7.13M6.68M6.72M13.70M20.57M20.81M
Total Liabilities25.69M205.12M22.43M20.27M18.43M17.27M17.08M17.73M16.54M22.51M20.57M20.82M
Shareholders' Equity180.73M-14.68M10.68M21.52M33.62M41.67M10.28M20.90M31.38M42.28M49.46M-1.45M
Retained Earnings-357.27M-345.16M-270.39M-260.23M-245.56M-231.12M-218.41M-205.58M-193.22M-180.71M-172.25M-165.75M
Net Cash (Debt)201.52M187.30M29.27M36.40M48.11M55.40M23.25M34.36M42.91M61.31M66.40M15.55M
Shares Outstanding109.78M102.72M53.24M53.23M52.81M49.69M34.69M34.69M34.39M34.34M34.25M21.17M

This table shows 12 quarterly periods of Achieve Life Sciences's balance sheet, from Q3 2026 back to Q4 2023, across 15 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow QUIT's reporting calendar. What is a balance sheet?

More financial data